312 related articles for article (PubMed ID: 23246968)
1. The evolution of the TOR pathway and its role in cancer.
Beauchamp EM; Platanias LC
Oncogene; 2013 Aug; 32(34):3923-32. PubMed ID: 23246968
[TBL] [Abstract][Full Text] [Related]
2. mTOR in aging, metabolism, and cancer.
Cornu M; Albert V; Hall MN
Curr Opin Genet Dev; 2013 Feb; 23(1):53-62. PubMed ID: 23317514
[TBL] [Abstract][Full Text] [Related]
3. mTOR-what does it do?
Hall MN
Transplant Proc; 2008 Dec; 40(10 Suppl):S5-8. PubMed ID: 19100909
[TBL] [Abstract][Full Text] [Related]
4. Evolutionarily conserved regulation of TOR signalling.
Takahara T; Maeda T
J Biochem; 2013 Jul; 154(1):1-10. PubMed ID: 23698095
[TBL] [Abstract][Full Text] [Related]
5. An overview of the mTOR pathway as a target in cancer therapy.
Gentzler RD; Altman JK; Platanias LC
Expert Opin Ther Targets; 2012 May; 16(5):481-9. PubMed ID: 22494490
[TBL] [Abstract][Full Text] [Related]
6. Nutritional control of cell growth via TOR signaling in budding yeast.
Wei Y; Zheng XF
Methods Mol Biol; 2011; 759():307-19. PubMed ID: 21863495
[TBL] [Abstract][Full Text] [Related]
7. A longer and healthier life with TOR down-regulation: genetics and drugs.
Bjedov I; Partridge L
Biochem Soc Trans; 2011 Apr; 39(2):460-5. PubMed ID: 21428920
[TBL] [Abstract][Full Text] [Related]
8. [TOR-centric concept of regulation mitogenic, metabolic and energetic signal processing in cell].
Zubova SG; Shitikova ZhV; Pospelova TV
Tsitologiia; 2012; 54(8):589-602. PubMed ID: 23074850
[TBL] [Abstract][Full Text] [Related]
9. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.
Polivka J; Janku F
Pharmacol Ther; 2014 May; 142(2):164-75. PubMed ID: 24333502
[TBL] [Abstract][Full Text] [Related]
10. mTOR Signalling in Health and Disease.
Proud CG
Biochem Soc Trans; 2011 Apr; 39(2):431-6. PubMed ID: 21428914
[TBL] [Abstract][Full Text] [Related]
11. mTOR inhibitors in cancer therapy.
Zaytseva YY; Valentino JD; Gulhati P; Evers BM
Cancer Lett; 2012 Jun; 319(1):1-7. PubMed ID: 22261336
[TBL] [Abstract][Full Text] [Related]
12. mTOR signaling pathway and mTOR inhibitors in cancer therapy.
Gomez-Pinillos A; Ferrari AC
Hematol Oncol Clin North Am; 2012 Jun; 26(3):483-505, vii. PubMed ID: 22520976
[TBL] [Abstract][Full Text] [Related]
13. A role for TOR complex 2 signaling in promoting autophagy.
Vlahakis A; Powers T
Autophagy; 2014; 10(11):2085-6. PubMed ID: 25426890
[TBL] [Abstract][Full Text] [Related]
14. The mTOR pathway in lung cancer and implications for therapy and biomarker analysis.
Ekman S; Wynes MW; Hirsch FR
J Thorac Oncol; 2012 Jun; 7(6):947-53. PubMed ID: 22588151
[TBL] [Abstract][Full Text] [Related]
15. The role of the TOR pathway in mediating the link between nutrition and longevity.
Lushchak O; Strilbytska O; Piskovatska V; Storey KB; Koliada A; Vaiserman A
Mech Ageing Dev; 2017 Jun; 164():127-138. PubMed ID: 28315697
[TBL] [Abstract][Full Text] [Related]
16. mTOR Inhibition Role in Cellular Mechanisms.
Zaza G; Granata S; Caletti C; Signorini L; Stallone G; Lupo A
Transplantation; 2018 Feb; 102(2S Suppl 1):S3-S16. PubMed ID: 29369970
[TBL] [Abstract][Full Text] [Related]
17. Metabolic control by target of rapamycin and autophagy during ageing - a mini-review.
Markaki M; Tavernarakis N
Gerontology; 2013; 59(4):340-8. PubMed ID: 23594965
[TBL] [Abstract][Full Text] [Related]
18. mTOR in Brain Physiology and Pathologies.
Bockaert J; Marin P
Physiol Rev; 2015 Oct; 95(4):1157-87. PubMed ID: 26269525
[TBL] [Abstract][Full Text] [Related]
19. Target of rapamycin signaling in leukemia and lymphoma.
Vu C; Fruman DA
Clin Cancer Res; 2010 Nov; 16(22):5374-80. PubMed ID: 20826559
[TBL] [Abstract][Full Text] [Related]
20. [Regulation of cancer behavior mediated by mTOR signal].
Hirao A
Nihon Rinsho; 2015 May; 73(5):773-8. PubMed ID: 25985629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
